Giananthony Rizzo[email protected]Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 2In the second part of our series on the coming shortage of SPECT radiopharmaceuticals, Giananthony Rizzo of Decision Resources Group examines other factors in the U.S. healthcare industry that could affect isotope prices in the future.November 17, 2016Nuclear MedicineIs the U.S. due for a shortage of SPECT tracers? Part 1A perfect storm is brewing in the global SPECT market that could see the prices of radiopharmaceuticals skyrocket over the next five years. A number of factors are coalescing that could lead to a shortage of SPECT tracers for years to come, according to this article by Giananthony Rizzo of Decision Resources Group.November 16, 2016Page 1 of 1Top StoriesMRIResting-state fMRI analysis reveals impact of blast exposuresA study of active and veteran U.S. special operations forces cohorts confirms how regions of the brain become altered.MRIMRI radiomics model predicts risk in women with DCISUltrasoundAIUM: Ob/gyn gaining ground on radiology in gynecologic ultrasoundUltrasoundAIUM: POCUS residency tracks improve skills for family med specialistsSponsor ContentElevate your patient's care with the capabilities of Cardiac PET/CT
